Treatment with omega-3 fatty acid ethyl esters in hyperlipoproteinaemias: comparative studies on lipid metabolism and thrombotic indexes.

[1]  C. Sirtori,et al.  Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout. , 1993, Biochimica et biophysica acta.

[2]  G. Franceschini,et al.  Fraudulent (and non fraudulent) fatty acids for human health , 1993, European journal of clinical investigation.

[3]  K. Bjerve,et al.  The enteral bioavailability of eicosapentaenoic acid and docosahexaenoic acid is as good from ethyl esters as from glyceryl esters in spite of lower hydrolytic rates by pancreatic lipase in vitro. , 1993, Biochimica et biophysica acta.

[4]  G. Franceschini,et al.  Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia. , 1992, The American journal of clinical nutrition.

[5]  J. Gustafsson,et al.  Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Franceschini,et al.  Omega-3 fatty acids selectively raise high-density lipoprotein 2 levels in healthy volunteers. , 1991, Metabolism: clinical and experimental.

[7]  D. Harats,et al.  Fish oil ingestion in smokers and nonsmokers enhances peroxidation of plasma lipoproteins. , 1991, Atherosclerosis.

[8]  F. Sacks,et al.  Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. , 1990, The American journal of cardiology.

[9]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.

[10]  M. Childs,et al.  Divergent lipoprotein responses to fish oils with various ratios of eicosapentaenoic acid and docosahexaenoic acid. , 1990, The American journal of clinical nutrition.

[11]  S M Grundy,et al.  Dietary influences on serum lipids and lipoproteins. , 1990, Journal of lipid research.

[12]  A. Donker,et al.  Dose-response effects of fish-oil supplementation in healthy volunteers. , 1990, The American journal of clinical nutrition.

[13]  J. Snook,et al.  Effect of diets high in butter, corn oil, or high-oleic acid sunflower oil on serum lipids and apolipoproteins in men. , 1990, The American journal of clinical nutrition.

[14]  T. Wilt,et al.  Fish oil supplementation does not lower plasma cholesterol in men with hypercholesterolemia. Results of a randomized, placebo-controlled crossover study. , 1989, Annals of internal medicine.

[15]  W. Harris,et al.  Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. , 1989, Journal of lipid research.

[16]  W. Harris,et al.  Omega-3 fatty acids in hypertriglyceridemic patients: triglycerides vs methyl esters. , 1988, The American journal of clinical nutrition.

[17]  G. Gianfranceschi,et al.  Controlled evaluation of fat intake in the Mediterranean diet: comparative activities of olive oil and corn oil on plasma lipids and platelets in high-risk patients. , 1986, The American journal of clinical nutrition.

[18]  G. Franceschini,et al.  Effects of storage on the distribution of high density lipoprotein subfractions in human sera. , 1985, Journal of lipid research.

[19]  C. von Schacky,et al.  Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. , 1985, The Journal of clinical investigation.

[20]  D. Sullivan,et al.  Triglyceride‐Lowering Effect of Marine Polyunsaturates in Patients with Hypertriglyceridemia , 1985, Arteriosclerosis.

[21]  J. Hautvast,et al.  Serum lipoproteins of healthy persons fed a low-fat diet or a polyunsaturated fat diet for three months. A comparison of two cholesterol-lowering diets. , 1982, Atherosclerosis.

[22]  H. Koren,et al.  Methods for Studying Mononuclear Phagocytes , 1981 .

[23]  B. Babior,et al.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. , 1973, The Journal of clinical investigation.

[24]  L. Avioli,et al.  Phenobarbital-induced alterations in vitamin D metabolism. , 1972, The Journal of clinical investigation.

[25]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[26]  C. Sirtori,et al.  Effects of EPA and DHA ethylesters on plasma fatty acids and on platelets, PMN and monocytes in healthy volunteers. , 1991, Advances in prostaglandin, thromboxane, and leukotriene research.

[27]  M. Childs,et al.  Effects of n-3 and n-6 fatty acid-enriched diets on plasma lipoproteins and apolipoproteins in heterozygous familial hypercholesterolemia. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[28]  G. Franceschini,et al.  Effects of fibrates on serum lipids and atherosclerosis. , 1988, Pharmacology & therapeutics.

[29]  P. Schwandt,et al.  Influence of polyunsaturated fats and fat restriction on serum lipoproteins in humans. , 1985, Metabolism: clinical and experimental.

[30]  L. Simons,et al.  On the effects of dietary n-3 fatty acids (Maxepa) on plasma lipids and lipoproteins in patients with hyperlipidaemia. , 1985, Atherosclerosis.

[31]  S. Rössner,et al.  Effects of Hypolipidemic Regimes on Serum Lipoproteins , 1974 .